Abbott Laboratories
ABTFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
41,950
Cost of Revenue
20,625
Gross Profit
21,325
Gross Margin
50.8%
Operating Income
6,825
Operating Margin
16.3%
Net Income
13,402
Net Margin
31.9%
EPS (Basic)
$7.67
EPS (Diluted)
$7.64
EBITDA
10,834
EBITDA Margin
25.8%
2023
12/31/2023
Revenue
40,109
Cost of Revenue
20,072
Gross Profit
20,037
Gross Margin
50.0%
Operating Income
6,435
Operating Margin
16.0%
Net Income
5,723
Net Margin
14.3%
EPS (Basic)
$3.30
EPS (Diluted)
$3.27
EBITDA
10,605
EBITDA Margin
26.4%
2022
12/31/2022
Revenue
43,653
Cost of Revenue
21,330
Gross Profit
22,323
Gross Margin
51.1%
Operating Income
8,362
Operating Margin
19.2%
Net Income
6,933
Net Margin
15.9%
EPS (Basic)
$3.94
EPS (Diluted)
$3.91
EBITDA
11,888
EBITDA Margin
27.2%
2021
12/31/2021
Revenue
43,075
Cost of Revenue
19,861
Gross Profit
23,214
Gross Margin
53.9%
Operating Income
9,200
Operating Margin
21.4%
Net Income
7,071
Net Margin
16.4%
EPS (Basic)
$3.97
EPS (Diluted)
$3.94
EBITDA
12,159
EBITDA Margin
28.2%
2020
12/31/2020
Revenue
34,608
Cost of Revenue
17,231
Gross Profit
17,377
Gross Margin
50.2%
Operating Income
5,291
Operating Margin
15.3%
Net Income
4,495
Net Margin
13.0%
EPS (Basic)
$2.52
EPS (Diluted)
$2.50
EBITDA
9,003
EBITDA Margin
26.0%